Levi & Korsinsky Reminder for Actinium Investors of Pending Class Action Lawsuit
Investors who have holdings in Actinium Pharmaceuticals, Inc. (ATNM) need to be aware of an impending class action lawsuit. The law firm of Levi & Korsinsky is urging investors to take action promptly as the deadline for appointing a lead plaintiff is fast approaching on May 27, 2025.
The class action lawsuit, which centers around Actinium Pharmaceuticals, Inc., is something that investors should pay close attention to. The deadline for appointing a lead plaintiff to represent the class in the lawsuit is just around the corner. It is crucial for investors with a stake in Actinium Pharmaceuticals, Inc. to understand the implications of this legal action and act accordingly before the deadline passes.
Investors who have invested in Actinium Pharmaceuticals, Inc. (ATNM) should note that there is an ongoing class action lawsuit that they should be aware of. Levi & Korsinsky, the law firm handling the case, has issued a reminder to investors to take action before the May 27, 2025 deadline for appointing a lead plaintiff.
The impending class action lawsuit involving Actinium Pharmaceuticals, Inc. (ATNM) is a significant development that investors need to take note of. The law firm Levi & Korsinsky has issued a reminder about this pending legal action and the approaching deadline for appointing a lead plaintiff, which is set for May 27, 2025.
Investors holding shares in Actinium Pharmaceuticals, Inc. (ATNM) should be mindful of the pending class action lawsuit concerning the company. Levi & Korsinsky, the law firm handling the case, is reminding investors to act swiftly as the deadline for appointing a lead plaintiff is on May 27, 2025.
The potential class action lawsuit involving Actinium Pharmaceuticals, Inc. (ATNM) is an important matter for investors to be aware of. Levi & Korsinsky, the law firm overseeing the case, is stressing the urgency of the situation and is advising investors to take action promptly before the May 27, 2025 deadline for appointing a lead plaintiff.